lercea glp 1 Zvlzvl Glp-1 Oral Solution, Digestive And Energy Supp The Unstoppable Rise of GLP-1

10.1038/s41598-020-73815-5

After a median follow-up of 3.2 years (duration of drug exposure 2.4 years) the primary outcome was reduced in the exenatide treated group, but this difference just missed achieving statistical significance (HR 0.91

Fralick, M., Colacci, M., Odutayo, A., Siemieniuk, R., & Glynn, R

These effects make GLP-1 a powerful tool in managing weight and blood sugar levels, which is why it has become a focal point in the development of medications for diabetes and obesity

Follow-up measurements taken during the 90 days on either side of these post-index dates were valid, with the closest measurement to 180/365 days post-index used as the follow-up value if multiple measurements were available